Cargando…

Small-sized colorectal cancer cells harbor metastatic tumor-initiating cells

Colorectal cancer (CRC) is heterogeneous and contains different-sized cells. Recent studies have shown that tumor-initiating cells (TICs) are involved in cancer initiation, recurrence and metastasis. However, connections between cancer cell size and stem-like properties are largely unknown. Here we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mu, Lei, Huang, Kaiyu, Hu, Yibing, Yan, Chang, Li, Xiaolan, Tao, Deding, Gong, Jianping, Qin, Jichao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746114/ https://www.ncbi.nlm.nih.gov/pubmed/29296212 http://dx.doi.org/10.18632/oncotarget.22392

Ejemplares similares

The CEA(−/lo) colorectal cancer cell population harbors cancer stem cells and metastatic cells
por: Yan, Chang, et al.
Publicado: (2016)

Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer
por: Hu, Yibing, et al.
Publicado: (2015)

Sphere-forming assay vs. organoid culture: Determining long-term stemness and the chemoresistant capacity of primary colorectal cancer cells
por: Zhao, Hui, et al.
Publicado: (2019)

Hypoxic colorectal cancer cells promote metastasis of normoxic cancer cells depending on IL-8/p65 signaling pathway
por: Mi, Yulong, et al.
Publicado: (2020)

Lactate promotes metastasis of normoxic colorectal cancer stem cells through PGC-1α-mediated oxidative phosphorylation
por: Liu, Shuang, et al.
Publicado: (2022)

Expression of HAX-1 in colorectal cancer and its role in cancer cell growth
por: LI, XIAOLAN, et al.
Publicado: (2015)

Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer
por: Min, Jiang, et al.
Publicado: (2015)

Ovary does harbor stem cells - size of the cells matter!
por: Bhartiya, Deepa, et al.
Publicado: (2020)

KDM4B plays an important role in mitochondrial apoptosis by upregulating HAX1 expression in colorectal cancer
por: Li, Haijie, et al.
Publicado: (2016)

Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?
por: Jung, Hyun Ae, et al.
Publicado: (2020)

Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation
por: Chantharasamee, J., et al.
Publicado: (2019)

Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation
por: Yamane, Hiromichi, et al.
Publicado: (2013)

Metastatic Patterns of Mediastinal Lymph Nodes in Small-Size Non-small Cell Lung Cancer (T1b)
por: Wu, Yijun, et al.
Publicado: (2020)

Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency
por: Cohen, Romain, et al.
Publicado: (2021)

Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer
por: Shen, Jie, et al.
Publicado: (2018)

Correction: Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signaling in breast cancer
por: Shen, Jie, et al.
Publicado: (2023)

Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion
por: Cai, Cun-Liang, et al.
Publicado: (2019)

EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
por: Le, Xiuning, et al.
Publicado: (2023)

How small could a pup sound? The physical bases of signaling body size in harbor seals
por: Ravignani, Andrea, et al.
Publicado: (2017)

Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring BRAF mutations
por: Wang, Haowei, et al.
Publicado: (2023)

FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non‐Small Cell Lung Cancers Harboring BRAF V600E Mutations
por: Odogwu, Lauretta, et al.
Publicado: (2018)

Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
por: Le, Xiuning, et al.
Publicado: (2023)

Postoperative management for non-small cell lung cancer harboring EGFR mutations
por: Tanaka, Fumihiro, et al.
Publicado: (2020)

Branchial Cleft Cyst Harbors Metastatic Papillary Thyroid Carcinoma
por: Marotta, Dario A, et al.
Publicado: (2021)

Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements
por: Pisano, Chiara, et al.
Publicado: (2022)

Pyoderma Gangrenosum as the Initial Manifestation of Small Cell Lung Cancer with Dermatomyositis
por: Li, Man, et al.
Publicado: (2017)

Multicenter real‐world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non‐small cell lung cancer
por: Lee, Su Yeon, et al.
Publicado: (2021)

Clinicopathological and computed tomography features of patients with early-stage non-small-cell lung cancer harboring ALK rearrangement
por: Hou, Xiaoming, et al.
Publicado: (2023)

Metastatic-initiating cells and lipid metabolism
por: Benitah, Salvador Aznar
Publicado: (2017)

Progress in Treatment of Non-Small Cell Lung Cancer Harboring HER2 Aberrations
por: Ni, Jun, et al.
Publicado: (2021)

Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations
por: Hsu, Ping-Chih, et al.
Publicado: (2022)

To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations
por: Cai, Ruoxue, et al.
Publicado: (2023)

FDA Benefit‐Risk Assessment of Osimertinib for the Treatment of Metastatic Non‐Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation
por: Odogwu, Lauretta, et al.
Publicado: (2017)

Efficacy of Second-line Tyrosine Kinase Inhibitors in the Treatment of Metastatic Advanced Non-small-cell Lung Cancer Harboring Exon 19 and 21 EGFR Mutations
por: Zheng, Zhen, et al.
Publicado: (2017)

Pattern of Treatment Initiation and Outcomes for Patients With Metastatic Non-small Cell Lung Cancer in Ontario
por: Ding, Jerry W, et al.
Publicado: (2022)

Detection of metastatic cancer cells in mesentery of colorectal cancer patients
por: Luo, Xue-Lai, et al.
Publicado: (2017)

Tyrosine Kinase Inhibitors Could Be Effective Against Non-small Cell Lung Cancer Brain Metastases Harboring Uncommon EGFR Mutations
por: Ma, Chunhua, et al.
Publicado: (2020)

Cost-Effectiveness of Tepotinib Versus Capmatinib for the Treatment of Adult Patients With Metastatic Non–Small Cell Lung Cancer Harboring Mesenchymal–Epithelial Transition Exon 14 Skipping
por: Yang, Mo, et al.
Publicado: (2023)

Cell Size and the Initiation of DNA Replication in Bacteria
por: Hill, Norbert S., et al.
Publicado: (2012)

AF1q Mediates Tumor Progression in Colorectal Cancer by Regulating AKT Signaling
por: Hu, Jingwei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_05flibfvrp4vud66hks1bkd20c